Sex- and afferent-specific expression of Neuropeptide-Y receptors in the baroreflex afferent pathway contributes to sexual dimorphism in blood pressure regulation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for estrogen-Y1R modulation of baroreflex in animals; leaves open translation to human hypertension management.
// Yang Liu 1, * , Di Wu 2, * , Mei-Yu Qu 2, * , Jian-Li He 2 , Mei Yuan 1 , Miao Zhao 2 , Jian-Xin Wang 2 , Jian He 2 , Lu-Qi Wang 2 , Xin-Jing Guo 1 , Meng Zuo 1 , Shu-Yang Zhao 2 , Mei-Na Ma 2 , Jun-Nan Li 1 , Weinian Shou 3 , Guo-Fen Qiao 1, 2 , Bai-Yan Li 1 1 Department of Pharmacology, Harbin Medical University, Harbin, China 2 Key Laboratory of Cardiovascular Research of Ministry of Education, Harbin Medical University, Harbin, China 3 Riley Heart Research Center, Division of Pediatric Cardiology, Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA * These authors have contributed equally to this work Correspondence to: Bai-Yan Li, email: liby@ems.hrbmu.edu.cn Guo-Fen Qiao, email: qiaogf88@163.com Keywords: neuropeptide Y, baroreflex, nodose ganglion, nucleus tractus solitarii, whole-cell patch techniques Received: October 27, 2015 Accepted: July 16, 2016 Published: September 07, 2016 ABSTRACT Background: Molecular and cellular mechanisms of neuropeptide-Y (NPY)-mediated gender-difference in blood pressure (BP) regulation are largely unknown. Methods: Baroreceptor sensitivity (BRS) was evaluated by measuring the response of BP to phenylephrine/nitroprusside. Serum NPY concentration was determined using ELISA. The mRNA and protein expression of NPY receptors were assessed in tissue and single-cell by RT-PCR, immunoblot, and immunohistochemistry. NPY was injected into the nodose while arterial pressure was monitored. Electrophysiological recordings were performed on nodose neurons from rats by patch-clamp technique. Results: The BRS was higher in female than male and ovariectomized rats, while serum NPY concentration was similar among groups. The sex-difference was detected in Y 1 R, not Y 2 R protein expression, however, both were upregulated upon ovariectomy and canceled by estrogen replacement. Immunostaining confirmed Y 1 R and Y 2 R expression in myelinated and unmyelinated afferents. Single-cell PCR demonstrated that Y 1 R expression/distribution was identical between A- and C-types, whereas, expressed level of Y 2 R was ~15 and ~7 folds higher in Ah- and C-types than A-types despite similar distribution. Activation of Y 1 R in nodose elevated BP, while activation of Y 2 R did the opposite. Activation of Y 1 R did not alter action potential duration (APD) of A-types, but activation of Y 2 R- and Y 1 R/Y 2 R in Ah- and C-types frequency-dependently prolonged APD. N-type I Ca was reduced in A-, Ah- and C-types when either Y 1 R, Y 2 R, or both were activated. The sex-difference in Y 1 R expression was also observed in NTS. Conclusions: Sex- and afferent-specific expression of Neuropeptide-Y receptors in baroreflex afferent pathway may contribute to sexual-dimorphic neurocontrol of BP regulation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: